Heterogeneous treatment effect estimation in survival analysis has become a critical component in high-stakes applications, including precision medicine. The unique challenges posed by right-censored survival data, such as censoring and unobserved counterfactuals, have hindered the development of effective estimation methods. To address this, researchers have introduced SurvHTE-Bench, a benchmark for evaluating heterogeneous treatment effect estimation methods in survival analysis1. This benchmark provides a standardized framework for assessing the performance of various estimation methods, facilitating the identification of the most effective approaches. The development of SurvHTE-Bench has significant implications for fields such as precision medicine, where accurate estimation of treatment effects is crucial. As AI continues to advance, the ability to effectively estimate heterogeneous treatment effects will play a critical role in informing policy and decision-making, making it essential for practitioners to stay abreast of these developments.